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Uruversitc de Man·"kech . M arr.1kech, Morocco 
The transition of the late anagen to the catagen phase 
is concOlnitant with the disappearance of perifollic-
ular capillaries, and therefore cyclical hair growth 
might depend on the ability of the derInal papilla to 
synthesize and release soluble growth and differenti-
ation factors toward pre-existing capillaries. We 
characterized an angiogenic growth factor in the 
conditioned InediuIn of derInal papilla cells indistin-
guishable froIn vascular endothelial growth factor as 
judged by biocheInical and iInInunologic criteria. 
I t has been postulated that the regulation of hair growth may involve complex interactions of diffusible facto.rs such as hormones and growth facto rs released by the dermal papilla [1-3] th at would act on hair growth [4 ,5]. Several attempts to identify such growth factors promoting dermal papilla 
cell (DPC) proliferation have been undertaken . In the course of 
identifying such growth factors controlling cyclica l hair growth, 
basic fibrobla st growth factor (bFGF) expression has been reported 
as varying during foUicle development [3,6,7]. H air development 
might also be linked to blood vessel proliferation, beca use hair loss 
is preceded by a disappearance during the catagen phase of the 
capillary network embedding tbe papilla [8]. 
In the course of characterizing putative autocrine growth factors 
for DPC we demonstrated that papilla-derived cells express ill I/i l/ £) 
and ill Il itro a mitogen indistingu.ishab.le from vascular endothelial 
gwwth factor (VEGF). VEGF [9] , al so Imown as vascular perme-
ability factor [10] o r vasculotropin [11], is considered to be one of 
til e more potent angiogenic growth factors released by norma1 and 
tumor ce lls [9-12] . Although its mitogenic activity h as been 
reported as restricted ill pirro to vascular endothelial cells [9 -12] and 
illterleukin-2-dependent lymphocytes [13] , we demonstrated that 
DPC cells express function al VEGF receptors m ediating prolife ra-
tion and migration . In contrast, root sheath fibroblasts (RSF) were 
not found to be sensitive to VEGF. The autocrine rol e ofVEGF for 
DPC was documented by the demonstration that the bioactivity of 
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In addition, these cells bind vascular endothelial, 
growth factor on two binding sites and proliferate or 
Inigrate in the presence of this growth factor. More-
over, neutralizing antibodies inhibit these biologic 
effects, confirIning that vascular endothelial growth 
factor Inight contribute to hair growth either by 
acting directly on papilla cells or by stiInulating the 
local vascularization. ] Invest Del't'ta.toll06:17-23, 1996 
the DPC conditioned medium for DPC or fetal bovin e aortic 
endothelial (FBAE) cells was abolished by anti-VEGF antibodies. 
MATERIALS AN D METHODS 
Cell Culture and Reagents Dennal papillae were isolated from rat 
vibdssae follicles by the tecllluque of Jahoda and Oliver (14 J. Several 
papillae were placed in 35-mm cultnre dishes containing 21111 ofDulbecco's 
modified Eagle's medjul11 (DME M) supplemented w ith 20% fetal bovine 
serum , penkiLliJl (100 units/ ml), and streptomycin (1 00 j.Lg/ ml) . Medium 
was changed every 3 d. After rcaching confluen ce (3- 4 weeks). DPC wcre 
harvested using 0.05% trypsin , 0.02% ethylenediamin etetraacetic acid solu-
tion and further subcultured in DMEM containing 10% fetal bovine se rum 
and antibiotics . All ce ll cu ltures were incubated at 37°C in a humid i.fied 5% 
CO2 atmosphere . 
For RSF cultures, small pieces were dissected from the mesenchymal 
sheath cnvelopjng the tat hair follicle and placed in 35-l11m culture dishes. 
T he further stcps of RSF cultures were the same as D PC. 
FBAE wcrc grown in DMEM supplemented with 10°;" newborn bovin e 
serum , pen.i cillin (100 units/ml), and streptomycin (100 j.Lg/ ml). Srock 
cultures received 1 ng/ml of bFGF every o ther day as dcscdbed [15J . 
Recombinant YEGF 165 was prepared in insect ce lls in fec ted by a 
recombinant baculovirus carryjng the VEGF 165 sequcnce [1 6J. R.ccombi-
nan t bFGF was prepared in Escher;ch;a coli as descdbed [1 7]. Anti-VEGF 
antibodies were raised in rabbits by monthly injections in lymph nodes of 1 0 
j.Lg of recombinant VEGF 165. IgG was puri.fied by pro tein A sepharose 
followed by affinity chromatography for recombinant VEGF 165 and did not 
cross- react w ith acidic or basic FGF. The unrctained fraction was recycled 
on this affinity column until the IgG could not recognize VEGF in an 
enzyme-linked immunosorbent assay (ELISA) and was further used as a 
control antibody. Anti-bFGF IgG was prepared and purified as described 
(1 8]. 
Immunohistochemistry Frozen scc tjons of rat vibrissae fo lljcles or 
cultured D PC grown on covers lides were fixed 5 min with acetone. and 
endogeno us peroxidase was inhjbited by incubation with 0 .03% H 20 2 . The 
sLides wCre then incubated with 1 j.Lg/ml of iml11uno purified an ti-VEGF IgG 
o r contro l IgG diluted in phosphate-buffe red saline for 45 min at 3rc. After 
rinsing the slides, we added 1:1000 dilution of goat blotinylated anti-rabbit 
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IgG, and the streptavidin-biotin complex was incubated for 10 min and 
detected with 3-amino-9-ethylcarbazole as chromogen. In control experi-
ments the slides received 1 /Lg/ml of control IgG instead of VEGF 
affmity-purified IgG. 
Purification of the Conditioned Medium DPC or RSF cells were 
grown in 560-cm2 plates until conAuency (5 X 107 cells per plate). The 
plates were then rinsed twice with serum-fi'ee medium and incubated in 120 
ml of serum-free medium supplemented with ,mtibiotics and 5 fLg/m l of 
transfenin and insulin . After 48 h cul ture medium was collected frolll two 
plates, centrifuged, concentrated by ammonium sulf.,te precipitation 
(500 gil), further dia lysed against 10 mM Tris, pH 7.4, and 50 mM NaCI, 
and then loaded on a heparin-sepharose affinity column (4 X 2 mm) . T he 
retajned material was subsequently eluted by a NaCI gradient. Fractions of 
0.5 ml were collected and processed for bioassays. 
The molecular mass of VEGF-like bioactivity was analyzed by Western 
blot. Purified extracts from tile condjtioned media were separated on a 12% 
polyacrylamide gel foUowed by transfer to njtrocellulose. The filters were 
stained with Ponceau red, treated with 5'Yo non-fat mi lk in 10 mM Tlis, 150 
111M NaCI, 0.05% Tween 20, pH 7.4, and incubated with 2 fLg/m l of 
immunopurified anti-VEGF IgG. Immunoreactive proteins were detected 
by incubation with peroxidase-conjugated anti -rabbit IgG, followed by 
development with luminol substrate. 
Binding of Iodinated VEGF VEGF was iodinated to a specific activity 
of 1-3 X 105 cpm/ ng fo llowing the chloramine T procedure as described 
[1.91. Cells were grown to subconAuence in six-well plates, tllen transfelTed 
to 4°C. All following operations were done in the cold . The cells were 
washed twice with 2 ml of binding bufFer (DMEM conta ining 20 mM 
HEPES buifer, pI-! 7.4. and 2 mg/ml gelati.n). For concentration-depen-
dence binding of 1251_VEGF experiments the DPC, RSF. and FBAE cells 
were incubated in a fina l volume of 0.5 ml with various amounts of 
iodinated VEGF in the absence or the presence of 1 /Lg of unlabeled VEGF 
per dish to determine the non-specific bindjng. The plates were washed 
after 3 h, the cells were lysed with 0.2 M NaOI-!, and radioactivity was 
counted in a gamma counter. T he data were analyzed according to 
Scatchard [20) . For cross-lin king experjments, 2 ng/ ml 1251_VEGF was 
added in a fl11 al volume of 1 ml in the absence Or the presence of200 ng of 
unlabeled VEGF. After 3 h, the dishes were washed with cold phosphate-
buffered sa line and the iodilUlted VEGF bound was cross-linked with 0.2 
mM disuccinjmidyl suberate for 15 min at room temperature and analyzed 
by gel electrophoresis followed by autoradiography. 
Growth Factor Bioactivities To measure the effect of growth factors 
on UPC and RSF proliferation, ce ll s were seeded at low density (20.000 
cells/well) in six-well cluster plates in 2 ml DMEM containing 5'X, feta l 
bovine serum. Different concentrations of human recombinant bFGF or 
VEGF were , .• dded every other day, and ce lls were trypsinized and counted 
on day 7. 
Cell migration assays were performed in a Boyden chamber assay [21 ]. 
T he lower compartment (0 .35 ml) contained different concentrations of 
bFGF or VEGI' . Cells gently trypsin ized were h011logeneized in serum-fiec 
DMEM and placed in the upper compartment (2 X 105 in 0.4 ml). T he ce lls 
were incubated for 4 h at 37"C in a humidified incubator with 5% CO2, At 
the end of the incubation, the fi lter (8 /Lm pore) separating the two 
compartments was fixed with methanol and sta ined with hematoxylin. The 
migration index is defined as the number of ce lls attached to the filter. To 
quantify ce ll migration, four fie lds random ly chosen were photographed. 
VEGF content was assayed by radio-receptor using FBAE cells as target 
ce ll s as previously described 122 1. BrieAy, subconAuent cell s seeded in 
12-well cluster plates ce ll s were incubated 3 h at 4°C in DMEM containing 
0.2% !,;c1atin and 2 ng/ml iodinated VEGF. At the end of the incubation 
period. the plates were rinsed. the cells lysed with 0.2 M NaOI-!. and the 
rad ioactivity counted in a gallltl13 CO lln ter. 
RESULTS 
VEGF Is Synthesized by DPC To localize VEGP in the bulb 
fo llicle, we carried out an immuno histochemica l staining using 
purified antibodies aga inst VEGF. Staining was detected on ly in the 
dermal papilla duri ng the anagen phase (Fig 1A). More than 50% of 
the ce lls were labeled. By contrast, no VEGP immunoreactivity was 
detected during the catagen and the telogen phases. 
C ul tu red OPC also expressed VEGP (Fig 2A). Sta in ing was 
located in the cytoplasm and was particularly marked in the 
perinuclear area. In each case, contro ls incubated with IgG purified 
fi'om the same batch but specifica ll y depl eted in anti - VEGP IgG 
showed no immunoreactivity (F igs 1B and 2B) . 
THE JOURNAL OF INVESTIGATIVE IJER.MATOLOGY 
To ascertain that the immunoreactive VEGF detected ;/1 s;1II 
corresponded to VEGF-l ike bioactivity, the conditioned m edia of 
DPC was concentrated and chromatographed on h eparin-Sepll a-
rose a£fulity columns. The eluted fractions were examined for their 
abili ty to stimulate FBAE cell proliferation , and the ir VEGF conten l 
was determined by radioreceptor assay. Both bioactivities were 
co-purified and e lu ted by 0.8 M NaCI (data not shown). Similar 
experime nts showed that RSF-conditi oned medium purified on 
h eparin-Sepharose d id n ot contain FBAE cell mitogenic activity or 
VEGF-like bioactivity. The fi'actions e luted a t 0.6-0.8 M NaCi 
were pooled and their VEGF-li ke concentration was measured b)' 3 
radioreceptor assay. Comparison of th e d ata showed that the slopes 
of the curves representing the binding of iodinated VEGF as a 
fun ction of the doses of recombinant VEGF and purifi ed OPC-
conditioned medium were parallel and allowed the calculation of 
VEGF-like bioactivity in the purifi ed extract (Fig 3) . Ten microli-
te rs of DPC-CM induced a competition similar to th at obtained in 
the presence of 3.5 ng VEGF, and therefore the concentration of 
VEGF was estimated as 437 ng per m l of purified extract assuming 
a yield of80% for VEGF purifi cation on heparin-Sepharose [11], or 
1.8 ng/ml of conditioned medium. 
To furth er cOI1.firm that the VEGF-like bioactivity was structur-
ally related to VEGF, a Western blot ana lysis using immunopurified 
anti-VEGF IgG was performed. A band migrating at M, = 46 kDa, 
indistinguish able fi'om that of recombinant VEGF, WaS visu alized 
by this approach (Fig 4). 
VEGF Binds t o DPC Concentration dependence of binding of 
iodinated VEGF was determined on DPC, RSF, and FBAE cells. 
RSF did not bind VEGF in a saturable and specific manner, but 
DPC and FBAE were able to bind VEGF in a saturable and specific 
manner. Scatchard analysis of th e data favored two binding sites for 
both cell s w ith kD of9 and 63 pM, corresponding to 540 and 1860 
binding sites per OPC and kD of 2 and 98 pM, corresponding to 
1,600 and 24,000 binding sites per FBAE cell (Fig 5) . By contrast, 
RSF cell s did not bind VEGF. 
Cross-lin king of iodinated VEGF and subsequent an alys is by 
polyacrylamide gel electrophoresis revealed the presence of one 
molecular species migrating at M , = 250 kOa. Addition of un la-
be led VEGF inhibi ted the intensity of the band almost totally, 
w h ereas the omission ofDSS failed to cross-link iodinated VEGF to 
its receptor (Fig 6). IfVEGF migrates as a M , = 45 kDa molecular 
species, the M, calcu lated for the VEGF rece ptor appea rs to 
contribute approximately 205 kDa. 
VEGF Is Mitogenic for DPC T h e binding of VEGF to OPC 
membranes on a m olecula r species with a m ass similar to that 
reported fo r the VEGF receptor prompted us to see w h ether VEGF 
could stim ul ate the prolife ration or the migration of these cells. 
Low-density DPC cell s were incubated in the presence of various 
concentrations of growth factors and counted after 7 d . It appeared 
that both VEGF and bFGF stimul ated the proliferation ofDPC as a 
function of the concentration (Fig 7A). The m;lxima l stimulation 
achi eved upon VEGF stim ul ation reached h alf that obtained with 
bFGF, but no synergistic effect between bFGF and VEGF could be 
observed. 
VEG F Is a n Autocrine Growth Factor for DPC T hat m ost of 
the bioactivity present in the condi tioned medium w as contributed 
by VEGF was confirmed by the demonstration tha t m ost of the 
mitogenic activ ity was n e u tra lized by affin ity-purified anti - VEGF 
IgG (Fig 7B) . Control experiments showed that this antibody was 
ab le to tota ll y block the mitogenic activity of exogenously added 
VEGF. . 
To ascertain that VEGF could act as an au tocrine growth factor , 
OPC cell migration was studied by the Boyden chamber assay. 
R ecombinant VEGF and DPC- de ri ved VEGF indu ced six- and 
tenfo ld inc reases in OPC migration respectively (Ta ble I) . Under 
the sa m e condi tions, the maximal e ffe ct obtain ed in the presence of 
bFGF induced on ly a twofo ld in c rease of OPC migration . Most of 
the ch emotactic activ ity indu ced by VEGF or puri~led OPC-
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Figure 1. VEGF is present in rat vibrissae follicle . Frozen sections o f rat vibrissae fo llicle were incubated with 1 p,g/ ml of anti-human reco mbinant 
VEG F (A ). Staining was observed in derm al papilla (DP). The con tro ls (B) were incuba ted w ith IgG depleted of anti-VEGF IgG. S')l1lp les were co unterstained 
with Maye r's hematoxylin . 
conditio ned m edium was abo lished by anti-VEG F antibodies as 
shown in Table I. 
DISCUSSIO N 
This study indica tes that rat dermal papilla cells bind and syn thesize 
VEGF, sugges ting the presence o f an autocrin e pro liferation and 
mig ratio n loop . 
T he identi fica tio n of VEGF in DPC ce ll s only du ring the anagen 
phase migh t be re levant to physiologic hair growth and di ffe renti-
ation. Altho ugh it is not p ossible to rule out that the immunoreac-
tiv ity detected in the derm al papill a might be associated w ith 
endo thelial cells , the high percentage of positi ve cells o bserved 
makes this hypothesis unlikely. T he presen ce of bioactive VEGF 
was [mther confirm ed ill lI i/l'o on DPC cells that do not express the 
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F igure 2 . VEGF is prescnt in cultured dcrmal papilla celIs . C ultured DPC cells were fixed and incubated with either 1. /-Lg/m l ofanti- VEGF (A) or 
control IgG (B). T he sljdes were further rinsed and incubated with peroxidase- conjuga ted goat anti-rabhit IgG. The reaction was visuaUzed b y the 
3-amjno- 9-e thylcarbazo le tcchnjq ue. Samples wece coun terstai ned with Mayer's hematoxylin . 
Von Willebrandt factor, an endoth elial specific marker. Although 
the expression ofVEGF has been described in hum an keratinocytes 
[22], we could not detect im munoreactivity of th e protein in the 
ketlltinocyte layer. T he anagen stage of the hair follicle is associated 
with an intense vasculatization, w hich mi gh t be controll ed by 
angiogenic growth factors such as VEGF and bFGF. Because bFGF 
can enhance the synthesis of VEGF in other cells such as vascular 
sm ooth mllscle cells [23J, it is possible that both factors might act ill 
synergy to enhance the local angiogenesis. Conversely, hair loss is 
preceded by the d isappearance oftbe capillary network embedding 
the papilb during the telogen phase. O ur data demonstrating tbe 
loss of expression of VEGF during the teIogen phase support this 
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Figure 3. OPC conditioned meruum contain s VEGF-like bioactiv-
ity. One hundred twenty milliliters of cu lture mediu111 conditioned by DPC 
or RSF were concentrated by ammoniu111 su lfate precipitation, dialyzed 
aga inst Tris 10 mM, pH 7.4, contain ing N aCI 0.05 M , loaded on a 
heparin-Sepharose affin ity co lu111n (0.2 X 0.4 cm) and eluted with a NaCI 
stepwise grad ient. Indiv id ual fi'actions were assayed fo r their abili ty to 
promote low-density FBAE ce ll pro liferation and U, eir VEGF conten t was 
determined by radiorecepcor assay. Fractions eluted at 0.6-0.8 M NaCI 
were pooled and their ab ility CO compete with the binding of iodinated 
VEGF to FBAE ce lls was compared CO that of recombinant human VEGF. 
hypothesis and confirm a recent report showing that VEGF immu-
noreactivity is decreased in hair foUicles ITom alopecia patients [24]. 
Alternatively VEGF acts also ill viIJo as a permeability factor and 
m ight be involved in the pathophys io logy of bullous diseases as 
suggested recently [25]. 
T he presence of a binding site for VEGF has been reported on 
membranes of cell s such as osteoblasts [26] , corneal endothelial 
ceUs or lens epithelial cells [27], or monocytes [28] that differentiate 
upon VEGF addition. Our data indicate that two classes of binding 
sites for VEGF arc present on DPC with apparent dissociation 





Fig ure 4. OPC-derived angiogenic growth factor is immunologi-
cally related to VEGF. Pooled fractions of heparin-Sepharose purified 
OPC-condi tio ned medium (30 ILl) and lOng of recorn binan t human VEGF 
were separated on a 12'Yu sodiu111 dodecylsulf.,te-polyacrylam ide gel elec-
trophoresis. T he proteins were then tra nsferred electrophoretica lly to 
nitrocellulose. T he fi lters were incubated with 0.5 ILg/ml of 3nti-VEGF 
IgG, washed·, and further incubated with a horseradish peroxidase-conju-
gated an ti-rabbit antibody. T he complex was visuali zed by a luminol 
substrate . 
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F igure 5. 1251 VEGF binds specifically to FBAE and OPC cells in a 
saturable fashion. SubconRuent OPC cell s (dinlllllllds) or FBAE (op ell 
sqllnrt's) seeded in six-weB cluster plates were incubated for 2 h at 4°C in the 
presence of increasing concentrations of ' ''I-Iabeled VEGF in a final 
volume of 500 ILl. Non-specific binding was determined in para llel dishes 
containing 500 ng of unlabeled ligand and subtracted from the values and 
represented less than 15% of the total binding at saturation. TIISCI: Scat-
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Figure 6. 1251 VEGF binds to a 200-kDa r eceptor on OPC cells. OPC 
were incubated in DMEM-gclatin buffer, pH 7.4 , with 8 ng/ml 12S , VEGF 
in the presence (Inlle 1) or the absence (Ialle.' 2 nlld 3) of 200 ng/ml of 
unlabeled VEGF. After 2 h at 4°C, the ce lls were washed and exposed (Inlles 
1 nlld 2) to 0.2 mM DSS at room temperature for 15 min. Lnlll' .1 received 
no OSS. The reaction was stopped by Tris-glycine, pH 7.S, and the ceBs 
were lysed with 1% Triton X 100 in 10 mM phosphate buffer, pH 6.9, 
containing 1 m M cthylenediaminetetraacetic acid and 20 fLg/m l of leupep-
tin, pepstatin , aprotil1in, and bcnzamidine, and analyzed in denaturing 
conditions 0 11 a 7'X, polyacrylamide slab gel, fo llowed by autoradiograph)' . 
Autoradiogram s were exposed fo r 5 d. 
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Figure 7. vEGF is mitogenic for DPC cells. A , DPC cell s w e re seed e d 
a t 20,000, cells/well . T riplica te dish es wcre exp osed to DME M sllppl e-
m c nted w ith 5% n ewborn bovine serum, and incre asing con ccn tra tions of 
V EGF, bFGF, or ?PCCpnr ifie d condi t ione d m edium w e re adde d every 
o ther da y , T h e m e d Ium was changed a t day 4, and the cell s w e re tryp sinise d 
a nd counte d at. da y 7, Data a re re presentativ e of four d eterminations. B, 0.3 
!"I o f the fractl~n ~ e lllted with 0.6 - 0.8 NaC I or 0.1 ng/ml o f VEG F were 
II1c ubate d 111 tnplica te dIsh es in the absen ce (solid s1"are) o r the presen ce 
. (d~lte(1 sqllnre) of 28 J-Lg/ml of a nti VEG F IgG and processed as above. E ach 
POUlt represen ts the Olean of three deternlinarion s. 
~n Vasclliar endothelial cells [19 ,29 -? 1] : It is therefore temptin g to 
specul ate tha t the presence of two bmdmg sites would d 
. . . correspon 
wIth the expressIOn of the. two cognate receptors ftk-1 [32- 34] and 
ftt~ l [35.'36]-. T hese findmgs, as w e ll as the description of the 
mltogem c effects of VEGF on interl eukin-2- stimulated Iympho.:. 
~yte~ [l3] strengthen the 'a ssu~nptiol1 that VEGF bioac tivity is not 
[ e s~l~ted to vascular .endo.thehal cells. Fur ther investigation will be 
nccessa ry to determme tlllle and space expression of VEGF in 
ana~en t~ teI?gen transition in the dermal papilla as w ell as the 
possIble Identity of VEGF with the autocrine bioactivity for DPC 
recently described .§ 
§ Tho rnto n MJ, E llio tt K, M essen ger AG, Randall V A: Pre liminary 
Table I. VEGF Is Chemotactic for DPC" 
Control VEG F DPC -CM 
Anti VEGr IgG J9 ::': 6 12'1 ::': 12 278 :t 35 + A n ti VEGF IgG 22 ::': 2 .5 17 + 2.4- 54 + 8 
" 175,000 DPC cells were seeded in the upper tank o r Boyden' s cham be r and VEG I' ~ 5 n~;'.~I) or 4% purI fied ope condi tioned mediulll bFGF (5 ng/ml) was placed in the 
Owel t.m ks" Some dJshcs received also 28 /.Lg/ml o f anti-V EGF IgG in til -' 1 't k Afte r a 4 h . b ' . I C .ower .111 s 
I . .' . - ~ Il C LI atlo n pen oe • chem o taxis was m easured by cOllnting the cell s on th~ 
owel (s urface of th e fal te r separating upper and lo w er wells. Each point represents th ~ 
mean . l11ean ± SO ) of fo ur determin atio ns, and the data arc rcprcscnt;l t ive' of ~Ilre'" 
c"' pcnmcnts. . . ....-: 
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